CCR6 and rheumatoid arthritis: Second, it would define the cellular pathway that regulates CCR6 expression and thereby open up the potential for therapeutic targeting, not only for RA but also for other inflammatory diseases associated with the CCR6DNP, including Crohn’s disease, Graves’ disease, and systemic sclerosis [4,7].